Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ng, Eduardo
NCT06587867: Seronegative Myasthenia Gravis - Efgartigimod IV	Recruiting	3	30	Canada	efgartigimod	University Health Network, Toronto	Efgartigimod, Generalized Myasthenia Gravis	05/25	05/25
MG_SCIG, NCT04728425: Subcutaneous Immunoglobulin for Myasthenia Gravis	Recruiting	2	30	Canada	subcutaneous immunoglobulin (SCIG), Cuvitru, intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG), Gammanorm + Cuvitru	University Health Network, Toronto	Myasthenia Gravis	06/23	12/23